🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ESMO announces the publication of the ESMO Tumour-Agnostic Classifier and Screener (ETAC-S), a new framework to assess the tumour-agnostic potential of #CancerTherapies with the aim to optimise the drug development process Annals of Oncology. 🔗ow.ly/rqmR50T6gHt

Extremely happy to share this meta-analysis evaluating immunotherapy in early breast cancer JAMA Oncology 🔗jamanetwork.com/journals/jamao… ➡️Thanks Tomás Pascual for the guidance. ➡️Thanks Dr. E Mittendorf and Sara Tolaney for writing the editorial. SOLTI #cancerresearch Vall d’Hebron Institute of Oncology (VHIO)

#IAmAPracticingOncologist

‼️ Would you like to dive into the topic of integrating #biomarkers into #ClinicalPractice & their role in #CancerTreatment? Do not miss the POWG 1 session on “Biomarkers in everyday clinical practice” #IAmAPractisingOncologist #BCSM #mCRPC #NGS #ESMO24 📌ow.ly/fVGI50TlJAj

Are you interested in contextualizing breakthroughs in perioperative therapy in early #BreastCancer, #BladderCancer & #RectalCancer? Join “POWG 2: Optimal perioperative systemic treatment in different tumours” #ESMO24 #IAmAPractisingOncologist 📌 ow.ly/PIuq50TlJMi

Very relevant point! Significant toxicity and without OS benefit. Difficult to argue without QoL & the patient perspective, a prerequisite.

In Innsbruck on breast cancer prevention hosted by #EUTOPS joined by colleagues from Karolinska Univ.sjuk and Karolinska Institutet Collaboration at its best! With Athanasios Zouzos and Angelique Flöter Rådestad. It was an honour to present on different perspectives and be part of this.

📣Be part of the future of #Sarcoma and #RareCancers care! Abstract submission for ESMO Sarcoma and Rare Cancers 2025 in Lugano (20-22 March) is open ⏰Submit by 7 January to share your work and connect with leading experts. #ESMOSarcomaAndRareCancers25 🔗ow.ly/KeeX50TASu2

#IAmAPracticingOncologist

The 2024 #NobelPrize in Physiology or Medicine focuses on the discovery of a vital regulatory mechanism used in cells to control gene activity. Genetic information flows from DNA to messenger RNA (mRNA), via a process called transcription, and then on to the cellular machinery

With >1000 participants and >500 abstracts presented - #CTOS2024 is the biggest platform connecting anyone interested in sarcoma research and therapy. Congratulations to the Program Directors for organizing the meeting Ana Sebio Jason Sicklick, Ashleigh Guadagnolo, Odion Binitie

OS results of KN-522 out in NEJM. Terrific news: adding pembro to neoadjuvant chemo for TNBC saves lives (5% 5-year Δ). Bad news: we’re stuck with giving 5 drugs to all patients with stage II-III TNBC, with permanent toxicity for many. Biomarkers, please! nejm.org/doi/full/10.10…

ESMO is pleased to announce the publication of the "ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update" in January 2025. #HealthForAll Annals of Oncology World Health Organization (WHO)

Join us in this webinar "optimising the managment of HR+ HER2- metastatic breast cancer". An international expert panel will be discussing the most recent data. @HansWildiers, Cristina Saura, Valentina Guarneri, Etienne Brain. See you on 22/01/2025 at 7pm (CET)

Yes we can and we will. But as we advocate on ESMO - Eur. Oncology GROW it should be done with a real multistakolders collaboration (AI, Oncologists and at least public health specialists) for the design, conduction and report of those studies.

Nurse Karo of Fiji Cancer Society has dedicated her career as a nurse and midwife to supporting women across Fiji 🇫🇯 to get timely screening and treatment for #CervicalCancer. Watch her story. ⬇ #CervicalCancerAwarenessMonth

🔔Check our latest JNCI publication on the real-world evidence of comprehensive cancer genome profiling as a supportive tool for treatment decision-making in patients with metastatic solid tumors shorturl.at/RqaIc #PrecisionOncology #CancerResearch

📣Jovenes oncologos de LATAM a no perderse el preceptorship de ESMO - Eur. Oncology que se llevará a cabo el 9 y 10 de abril 📆 antes del #ESMOSummit en Lima 🇵🇪 esmo.org/meeting-calend…

📢 #ShortHER 10-year survival data and TILs! First study showing prognostic role of TILs on OS in HER2+ early BC. Patients with TILs≥20% did not show any additional risk with shorter trastuzumab duration. #bcsm OncoAlert Maria Vittoria Dieci Università di Padova shorturl.at/CQTod

👉 Stay up to date with the latest evidence-based recommendations from the #ESMOGuidelines for the treatment of metastatic #breastcancer to optimise patient outcomes. Join this live discussion and submit your questions 🔗 ow.ly/qwpi50VX2bo